AAA
RXDX

Affinity Asset Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Affinity Asset Advisors’s Portfolio RXDX Stock Details RXDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-150,000
Closed -$16.1M – 88
2023
Q1 		$16.1M Buy
150,000
+75,000
+100% +$8.05M 5.31% 3
2022
Q4 		$8.25M Buy
75,000
+50,000
+200% +$5.5M 3.24% 6
2022
Q3 		$1.48M Buy
+25,000
New +$1.48M 0.41% 33